# Intraoperative ICG for Systemic Sclerosis

> **NCT03155464** · PHASE4 · WITHDRAWN · sponsor: **Duke University**

## Conditions studied

- Systemic Sclerosis

## Interventions

- **PROCEDURE:** Order of two elements of surgical procedure
- **DRUG:** Indocyanine Green

## Key facts

- **NCT ID:** NCT03155464
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-06-01
- **Primary completion:** 2018-01-23
- **Final completion:** 2018-01-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The device that was going to be studied was removed by Duke University shortly after the study was approved.
- **Last updated:** 2020-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03155464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03155464, "Intraoperative ICG for Systemic Sclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03155464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*